Drug resistance in basal cell carcinoma identifies the inner nuclear membrane as a critical GLI1 regulatory checkpoint

被引：0
|
作者：
Mirza, A. [1 ]
McKeller, S. A.
Oro, A. E. [2 ,3 ]
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 05期
关键词：
D O I：
10.1016/j.jid.2018.03.184
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
179
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 18 条
  • [1] Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
    Gerhard Regl
    Graham W Neill
    Thomas Eichberger
    Maria Kasper
    Mohammed S Ikram
    Josef Koller
    Helmut Hintner
    Anthony G Quinn
    Anna-Maria Frischauf
    Fritz Aberger
    Oncogene, 2002, 21 : 5529 - 5539
  • [2] Response of basal cell carcinoma to imiquimod was associated with the Gli1: Gli3 expression ratio
    Kanzaki, A.
    Kato, Y.
    Kariya, T.
    Kanda, Y.
    Shirai, K.
    Arai, T.
    Tsuboi, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (06) : 1406 - 1407
  • [3] Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
    Regl, G
    Neill, GW
    Eichberger, T
    Kasper, M
    Ikram, MS
    Koller, J
    Hintner, H
    Quinn, AG
    Frischauf, AM
    Aberger, F
    ONCOGENE, 2002, 21 (36) : 5529 - 5539
  • [4] GLI1 genotypes do not predict basal cell carcinoma risk: a case control study
    Andrea Watson
    Paul Kent
    Murad Alam
    Amy S Paller
    David M Umbach
    Joon Won Yoon
    Philip M Iannaccone
    David O Walterhouse
    Molecular Cancer, 8
  • [5] GLI1 genotypes do not predict basal cell carcinoma risk: a case control study
    Watson, Andrea
    Kent, Paul
    Alam, Murad
    Paller, Amy S.
    Umbach, David M.
    Yoon, Joon Won
    Iannaccone, Philip M.
    Walterhouse, David O.
    MOLECULAR CANCER, 2009, 8
  • [6] Dual degradation signals control Gli1 protein stability and basal cell carcinoma formation
    Huntzicker, E.
    Estay, I.
    Zhen, H.
    Lokteva, L.
    Jackson, P.
    Oro, A. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 17 - 17
  • [7] Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels
    Hatta, N
    Hirano, T
    Kimura, T
    Hashimoto, K
    Mehregan, DR
    Ansai, S
    Takehara, K
    Takata, M
    JOURNAL OF CUTANEOUS PATHOLOGY, 2005, 32 (02) : 131 - 136
  • [8] Loss of protein kinase Cα expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma
    Neill, GW
    Ghali, LR
    Green, JL
    Ikram, MS
    Philpott, MP
    Quinn, AG
    CANCER RESEARCH, 2003, 63 (15) : 4692 - 4697
  • [9] Utility of GLI1 RNA Chromogenic in Situ Hybridization in Distinguishing Basal Cell Carcinoma From Histopathologic Mimics
    Menge, Tyler D.
    Durgin, Joseph S.
    Hrycaj, Steven M.
    Brent, Ashley A.
    Patel, Rajiv M.
    Harms, Paul W.
    Fullen, Douglas R.
    Chan, May P.
    Bresler, Scott C.
    MODERN PATHOLOGY, 2023, 36 (10)
  • [10] Utility of GLI1 RNA in Situ Hybridization in Distinguishing Between Cutaneous Basal Cell Carcinoma and Other Epithelial Neoplasms
    Menge, Tyler
    Hrycaj, Steven
    Patel, Rajiv
    Harms, Paul
    Fullen, Douglas
    Chan, May
    Bresler, Scott
    LABORATORY INVESTIGATION, 2023, 103 (03) : S419 - S421
12